Cappello Joseph 4
4 · GENELUX Corp · Filed Jul 8, 2024
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Cappello Joseph
VP, Pharmaceutical Development
Transactions
- Award
Common Stock
2024-02-19+3,661→ 9,396 total - Award
Common Stock
2024-03-14+11,557→ 20,953 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of February 17, 2024.
- [F2]Represents RSUs that are fully vested as of March 14, 2024.